Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sun-Jine Van Bezooijen"'
Autor:
Gayle van der Kraaij, Celine Busard, Juul van den Reek, Stef Menting, Annelie Musters, Barbara Hutten, Menno de Rie, Wouter Ouwerkerk, Sun-Jine van Bezooijen, Errol Prens, Theo Rispens, Annick de Vries, Elke de Jong, Wim de Kort, Jo Lambert, Martijn van Doorn, Phyllis Spuls
Publikováno v:
Journal of Investigative Dermatology, 142(9), 2375-+. Nature Publishing Group
Journal of investigative dermatology, 142(9), 2375-2383.e6. Nature Publishing Group
van der Kraaij, G, Busard, C, van den Reek, J, Menting, S, Musters, A, Hutten, B, de Rie, M, Ouwerkerk, W, van Bezooijen, S-J, Prens, E, Rispens, T, de Vries, A, de Jong, E, de Kort, W, Lambert, J, van Doorn, M & Spuls, P 2022, ' Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis : First-Year Results of a Single-Blind Randomized Controlled Trial ', Journal of Investigative Dermatology, vol. 142, no. 9, pp. 2375-2383.e6 . https://doi.org/10.1016/j.jid.2022.01.033
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Journal of Investigative Dermatology, 142, 9, pp. 2375-2383.e6
Journal of Investigative Dermatology, 142(9), 2375-2383.e6. Nature Publishing Group
Journal of Investigative Dermatology, 142, 2375-2383.e6
Journal of investigative dermatology, 142(9), 2375-2383.e6. Nature Publishing Group
van der Kraaij, G, Busard, C, van den Reek, J, Menting, S, Musters, A, Hutten, B, de Rie, M, Ouwerkerk, W, van Bezooijen, S-J, Prens, E, Rispens, T, de Vries, A, de Jong, E, de Kort, W, Lambert, J, van Doorn, M & Spuls, P 2022, ' Adalimumab with Methotrexate vs. Adalimumab Monotherapy in Psoriasis : First-Year Results of a Single-Blind Randomized Controlled Trial ', Journal of Investigative Dermatology, vol. 142, no. 9, pp. 2375-2383.e6 . https://doi.org/10.1016/j.jid.2022.01.033
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Journal of Investigative Dermatology, 142, 9, pp. 2375-2383.e6
Journal of Investigative Dermatology, 142(9), 2375-2383.e6. Nature Publishing Group
Journal of Investigative Dermatology, 142, 2375-2383.e6
Introduction: Adalimumab is normally prescribed with methotrexate (MTX) in rheumatoid arthritis given the enhanced treatment effect and reduced antidrug antibody formation compared with adalimumab monotherapy (ADL). In psoriasis, the long-term treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::705059c885874d621eb5876dff42e1d0
https://pure.eur.nl/en/publications/9e5ee111-9e22-462d-97c4-41566601aeb1
https://pure.eur.nl/en/publications/9e5ee111-9e22-462d-97c4-41566601aeb1
Autor:
Celine Busard, Menting, Stef, Sun-Jine Van Bezooijen, Reek, Juul Van Den, Hutten, Barbara, Prens, Errol, Jong, Elke De, Doorn, Martijn Van, Spuls, Phyllis
SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documents.* (DOC 121 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::145e7b07607e5f4991b90c9e0c795008
Autor:
Celine Busard, Menting, Stef, Sun-Jine Van Bezooijen, Reek, Juul Van Den, Hutten, Barbara, Prens, Errol, Jong, Elke De, Doorn, Martijn Van, Spuls, Phyllis
SPIRIT 2013 checklist: recommended items to address in a clinical trial protocol and related documents.* (DOC 121 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ddfb7c2fadd3bd8166d5492bfe2dbf5